We also treated human and mouse hepatocytes with palmitic acid (PA), the most abundant fatty acid in HFD and in serum of NAFLD patients (Gambino et al. 2016), and assessed HMGB1 levels. This evidence concerns the gene HMGB1 and metabolic dysfunction-associated steatotic liver disease.